Acta Oncologica,
Год журнала:
2024,
Номер
63, С. 448 - 455
Опубликована: Июнь 20, 2024
Robust
optimization
has
been
suggested
as
an
approach
to
reduce
the
irradiated
volume
in
lung
Stereotactic
Body
Radiation
Therapy
(SBRT).
We
performed
a
retrospective
planning
study
investigate
potential
benefits
over
Planning
Target
Volume
(PTV)-based
planning.
Physics and Imaging in Radiation Oncology,
Год журнала:
2024,
Номер
31, С. 100627 - 100627
Опубликована: Июль 1, 2024
Advancements
in
radiotherapy
auto-segmentation
necessitate
reliable
and
efficient
workflows.
Therefore,
a
standardized
fully
automatic
workflow
was
developed
for
three
commercially
available
deep
learning-based
applications
compared
to
manual
safety
efficiency.
The
underwent
evaluation
with
failure
mode
effects
analysis.
Notably,
eight
modes
were
reduced,
including
seven
severity
factors
≥7,
indicating
the
effect
on
patients,
two
Risk
Priority
Number
value
>125,
which
assesses
relative
risk
level.
Efficiency,
measured
by
mouse
clicks,
showed
zero
clicks
workflow.
This
automation
illustrated
improvement
both
efficiency
of
Clinical and Translational Radiation Oncology,
Год журнала:
2025,
Номер
52, С. 100933 - 100933
Опубликована: Фев. 11, 2025
Highlights•Clinically
feasible
RT
plans
by
one-click
ML-based
workflow.•ML-based
within
investigator-dependant
variability.•High
potential
to
increase
efficency
and
accuracy.AbstractIntroductionThe
integration
of
artificial
intelligence
into
radiotherapy
planning
for
prostate
cancer
has
demonstrated
promise
in
enhancing
efficiency
consistency.
In
this
study,
we
assess
the
clinical
feasibility
a
fully
automated
machine
learning
(ML)-based
"one-click"
workflow
that
combines
segmentation
treatment
planning.
The
proposed
was
designed
create
clinically
acceptable
plan
inter-observer
variation
conventional
plans.MethodsWe
evaluated
fully-automated
on
five
low-risk
patients
treated
with
external
beam
compared
results
optimized
inverse
planned
based
contours
six
different
experienced
radiation
oncologists.
Both
qualitative
quantitative
metrics
were
analyzed.
Additionally,
dose
distribution
segmentations
(manual
vs.
manual
automation).ResultsThe
automatic
deep-learning
target
volume
revealed
close
agreement
between
expert
referring
Dice
Similarity-
Hausdorff
index.
However,
CTVs
had
significantly
smaller
than
(47.1
cm3
62.6
cm3).
provide
coverage
range
variability
observed
plans.
Due
CTV
PTV
(expert
contours)
lower
plans.ConclusionOur
study
indicates
tested
is
leads
comparable
This
represents
promising
step
towards
efficient
standardized
treatment.
Nevertheless,
cohort,
auto
associated
volumes
contours,
highlighting
necessity
improving
models
prospective
testing
automation
therapy.
Information,
Год журнала:
2025,
Номер
16(3), С. 215 - 215
Опубликована: Март 11, 2025
As
yet,
there
is
no
systematic
review
focusing
on
benefits
and
issues
of
commercial
deep
learning-based
auto-segmentation
(DLAS)
software
for
prostate
cancer
(PCa)
radiation
therapy
(RT)
planning
despite
that
NRG
Oncology
has
underscored
such
necessity.
This
article’s
purpose
to
systematically
DLAS
product
performances
PCa
RT
their
associated
evaluation
methodology.
A
literature
search
was
performed
with
the
use
electronic
databases
7
November
2024.
Thirty-two
articles
were
included
as
per
selection
criteria.
They
evaluated
12
products
(Carina
Medical
LLC
INTContour
(Lexington,
KY,
USA),
Elekta
AB
ADMIRE
(Stockholm,
Sweden),
Limbus
AI
Inc.
Contour
(Regina,
SK,
Canada),
Manteia
Technologies
Co.
AccuContour
(Jian
Sheng,
China),
MIM
Software
ProtégéAI
(Cleveland,
OH,
Mirada
Ltd.
DLCExpert
(Oxford,
UK),
MVision.ai
Contour+
(Helsinki,
Finland),
Radformation
AutoContour
(New
York,
NY,
RaySearch
Laboratories
RayStation
Siemens
Healthineers
AG
AI-Rad
Companion
Organs
RT,
syngo.via
Image
Suite
DirectORGANS
(Erlangen,
Germany),
Therapanacea
Annotate
(Paris,
France),
Varian
Systems,
Ethos
(Palo
Alto,
CA,
USA)).
Their
results
illustrate
can
delineate
organs
at
risk
(abdominopelvic
cavity,
anal
canal,
bladder,
body,
cauda
equina,
left
(L)
right
(R)
femurs,
L
R
pelvis,
proximal
sacrum)
four
clinical
target
volumes
(prostate,
lymph
nodes,
bed,
seminal
vesicle
bed)
clinically
acceptable
outcomes,
resulting
in
delineation
time
reduction,
5.7–81.1%.
Although
recommended
each
centre
perform
its
own
prior
implementation,
seems
more
important
due
methodological
respective
single
studies,
e.g.,
small
dataset
used,
etc.
ObjectivesTo
report
the
development
of
artificial
intelligence
(AI)-based
software
to
allow
for
autonomous
fusion
transrectal
ultrasound
and
multiparametric
magnetic
resonance
images
prostate
be
used
during
transperineal
biopsies.Materials
MethodsThis
study
was
approved
by
Institutional
Review
Board
(protocol
ID3167CESC).
The
automatic
biopsy
involved
three
steps:
1)
Developing
an
AI
component
segment
ultrasound;
2)
anatomical
structures
in
using
labeled
datasets
from
Cancer
Imaging
Archive
in-house
scans;
3)
register
segmented
a
three-step
process:
pre-alignment,
rigid
alignment,
elastic
fusion,
validated
measuring
lesion
distance
between
modalities.
Statistical
analysis
included
descriptive
statistics
Mann-Whitney
U
test,
evaluating
outcomes
with
Dice
scores
average
precision
metrics.ResultsThe
showed
score
0.87
test
set
75,357
28,946
annotations.
achieved
0.85
on
2,494
It
also
demonstrated
mean
Average
Precision
0.80
bounding
boxes
0.88
objects,
both
measured
at
50%
intersection
over
union
threshold.
reduced
median
resonance-ultrasound
8
mm
(IQR
6–9)
after
4
3–5)
(p<0.001).ConclusionA
data
processing
pipeline
were
created
ideally
biopsies.
Deleted Journal,
Год журнала:
2025,
Номер
31(5), С. 477 - 482
Опубликована: Март 5, 2025
Etwa
die
Hälfte
aller
Tumorpatienten
erhält
im
Laufe
der
Erkrankung
eine
Strahlentherapie,
entweder
als
alleinige,
kurative
Therapie,
Rahmen
multimodaler
Konzepte
neo(adjuvante)
Therapie
oder
zur
Palliation.
Technologische
Weiterentwicklungen
haben
dazu
beigetragen,
dass
gewünschte
Strahlendosis
immer
genauer
an
Zielstruktur
angeschmiegt
werden
und
damit
Belastung
gesunder
Gewebe
minimiert
kann.
Eine
Limitation
war
jedoch
bis
vor
einigen
Jahren,
Bestrahlungsplanung
für
gesamte
Behandlung
üblicherweise
auf
einer
prätherapeutischen
Planungs-Computertomographie
beruhte
anatomische
Veränderungen
Bereich
des
Zielvolumens
unter
meist
nicht
detektiert
konnten.
Diese
Unsicherheit
limitierte
in
manchen
Körperregionen
applizierbaren
Bestrahlungsdosen.
Mithilfe
adaptiven
Strahlentherapie
können
nun
durch
am
Linearbeschleuniger
integrierte,
optimierte
Bildgebung
solche
Veränderungen,
wie
z.
B.
Tumorschrumpfung
Lageveränderung
besonders
strahlenempfindlicher
Organe,
etwa
von
Darmschlingen,
unmittelbar
jeder
Bestrahlungsfraktion
erkannt
Bestrahlungsplan
passend
Anatomie
Tages
angepasst
werden.
Dies
ist
bei
abdominellen
Tumoren,
dem
Pankreaskarzinom
Lebertumoren,
aber
auch
zentral
gelegenen
Tumoren
Lunge
relevant
ermöglicht
Applikation
höherer
Der
Beitrag
gibt
einen
Überblick
über
Indikationen
adaptive
jeweiligen
Vorteile,
Herausforderungen
dazu,
künstliche
Intelligenz
Automatisierung
hier
Therapieoptimierung
beitragen.
European Radiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 8, 2025
Abstract
The
integration
of
machine-learning
technologies
into
radiology
practice
has
the
potential
to
significantly
enhance
diagnostic
workflows
and
patient
care.
However,
successful
deployment
maintenance
medical
(MedML)
systems
in
requires
robust
operational
frameworks.
Medical
operations
(MedMLOps)
offer
a
structured
approach
ensuring
persistent
MedML
reliability,
safety,
clinical
relevance.
are
increasingly
employed
analyse
sensitive
radiological
data,
which
continuously
changes
due
advancements
data
acquisition
model
development.
These
can
alleviate
workload
radiologists
by
streamlining
tasks,
such
as
image
interpretation
triage.
MedMLOps
ensures
that
stay
accurate
dependable
facilitating
continuous
performance
monitoring,
systematic
validation,
simplified
maintenance—all
critical
maintaining
trust
machine-learning-driven
diagnostics.
Furthermore,
aligns
with
established
principles
protection
regulatory
compliance,
including
recent
developments
European
Union,
emphasising
transparency,
documentation,
safe
retraining.
This
enables
implement
modern
tools
control
oversight
at
forefront,
reliable
within
dynamic
context
practice.
empowers
deliver
consistent,
high-quality
care
confidence,
aligned
evolving
standards
needs.
assist
multiple
stakeholders
models
available,
monitored
easy
use
maintain
while
preserving
privacy.
better
serve
patients
implementation
cutting-edge
clinicians
only
utilised
when
they
performing
expected.
Key
Points
Question
applications
becoming
adopted
clinics,
but
necessary
infrastructure
sustain
these
is
currently
not
well-defined
.
Findings
Adapting
machine
learning
concepts
enhances
ecosystems
improving
interoperability,
automating
monitoring/validation,
reducing
burdens
on
informaticians
Clinical
relevance
Implementing
solutions
eases
faster
safer
adoption
advanced
models,
consistent
for
clinicians,
benefiting
through
streamlined
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(11), С. 5386 - 5386
Опубликована: Июнь 4, 2025
Prostate
cancer
remains
a
major
global
health
challenge,
ranking
as
the
second
most
common
malignancy
in
men
worldwide.
Advances
diagnostic
and
therapeutic
strategies
have
transformed
its
management,
enhancing
patient
outcomes
quality
of
life.
This
review
highlights
recent
breakthroughs
imaging,
including
multiparametric
MRI
PSMA-PET,
which
improved
detection
staging.
Biomarker-based
diagnostics,
such
PHI
4K
Score,
offer
precise
risk
stratification,
reducing
unnecessary
biopsies.
Innovations
treatment,
robotic-assisted
surgery,
novel
hormone
therapies,
immunotherapy,
PARP
inhibitors,
are
redefining
care
for
localized
advanced
prostate
cancer.
Artificial
intelligence
(AI)
machine
learning
(ML)
emerging
powerful
tools
to
optimize
prediction,
treatment
personalization.
Additionally,
advances
radiation
therapy,
IMRT
SBRT,
provide
targeted
effective
options
high-risk
patients.
While
these
innovations
significantly
survival
minimized
overtreatment,
challenges
remain
optimizing
therapy
sequencing
addressing
disparities
care.
The
integration
AI,
theranostics,
gene-editing
technologies
holds
immense
promise
future
management.
Abstract
Radiation
therapy
is
a
localized
cancer
treatment
that
relies
on
precise
delineation
of
the
target
to
be
treated
and
healthy
tissues
guarantee
optimal
effect.
This
step,
known
as
contouring
or
segmentation,
involves
identifying
both
volumes
organs
at
risk
imaging
modalities
like
CT,
PET,
MRI
guide
radiation
delivery.
Manual
however,
time-consuming
highly
subjective,
despite
presence
guidelines.
In
recent
years,
automated
segmentation
methods,
particularly
deep
learning
models,
have
shown
promise
in
addressing
this
task.
However,
challenges
persist
their
clinical
use,
including
need
for
robust
quality
assurance
(QA)
processes
risks
associated
with
use
models.
review
examines
considerations
adoption
auto-segmentation
radiotherapy,
focused
volume.
We
discuss
potential
(eg,
over-
under-segmentation,
automation
bias,
appropriate
trust),
mitigation
strategies
human
oversight,
uncertainty
quantification,
education
professionals),
we
highlight
importance
expanding
QA
include
geometric,
dose-volume,
outcome-based
performance
monitoring.
While
offers
significant
benefits,
careful
attention
rigorous
measures
are
essential
its
successful
integration
practice.